Work

Melanin-like nanoparticles as a potential novel therapeutic approach in ADPKD

Year: 2024

Type: article

Abstract: In this issue of EMBO Molecular Medicine, Sun and colleagues report the development of a novel therapeutic approach, and preclinical proof-of-concept evidence of its efficacy, for Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Sun et al, 2024). L. Cassina and A. Boletta discuss the study by Sun et al, in this issue of EMBO Mol Med, that describes a new therapeutic approach based on melanin-like nanoparticles for Autosomal Dominant Polycystic Kidney Disease.

Source: EMBO Molecular Medicine

DOI: 10.1038/s44321-024-00173-4

Authors: Laura Cassina, Alessandra Boletta

Institution: IRCCS Ospedale San Raffaele

Language: English

Topic: Genetic and Kidney Cyst Diseases

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $6,890